Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02771626
Title Study CB-839 in Combination With Nivolumab in Patients With ccRCC and Other Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Calithera Biosciences, Inc
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Honor Health Scottsdale Arizona 85016 United States Details
Stanford University Palo Alto California 94304 United States Details
University of Colorado Aurora Colorado 80045 United States Details
University Cancer Blood Center Athens Georgia 30607 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02114 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Karmanos Caner Center Detroit Michigan 48201 United States Details
New York University New York New York 10016 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10655 United States Details
University Hospitals Cleveland Cleveland Ohio 44106 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Vanderbilt University Nashville Tennessee 37232 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Seattle Cancer Care Alliance/University of Washington Seattle Washington 98109 United States Details
Northwest Medical Specialties Tacoma Washington 98405 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field